Who is sponsoring NCT05854576?

NCT05854576 is sponsored by Soad Elsayed Abu douh.

What drugs are being tested in NCT05854576?

Interventions in NCT05854576: vascular acess.

What condition does NCT05854576 study?

NCT05854576 studies Disorders of Calcium and Bone Metabolism.

Is NCT05854576 still recruiting?

NCT05854576 is currently status unknown. Last updated 11 May 2023.

Last reviewed 2023-05-11 · How we verify

NCT05854576

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Markers of Metabolism and Vascular Access in ESRD

Status unknown Last updated 11 May 2023

What this trial tests

trial testing vascular acess in Disorders of Calcium and Bone Metabolism in 60 participants. Status unknown.

Timeline

1 September 2023

Primary endpoint
1 September 2024

1 November 2024

Quick facts

Lead sponsor	Soad Elsayed Abu douh
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	60
Start date	1 September 2023
Primary completion	1 September 2024
Estimated completion	1 November 2024

Drugs / interventions tested

vascular acess

Conditions studied

Disorders of Calcium and Bone Metabolism — all drugs for Disorders of Calcium and Bone Metabolism →

Sponsor

Soad Elsayed Abu douh

Who can join

Adults 18 to 95, any sex, with Disorders of Calcium and Bone Metabolism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim of the study is to determine the association of markers of mineral metabolism with vascular access out come (maturation, patency of vascular access\[AVF,AVG\])To verify the relationship between vascular access complication (AVF,AVG) and lower levels of 25(OH)D, higher levels of fibroblast growth factor 23 (FGF23) and serum calcium, phosphorus, parathyroid hormone (PTH) in patients with ESRD on regular hemodialysis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05854576 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Soad Elsayed Abu douh
Last refreshed: 11 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05854576.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing